The Valley Desk

EditorialThe Journal of allergy and clinical immunologyPublished

An LNP-CRISPR gene editing drug demonstrates efficacy and safety in patients with hereditary angioedema following in vivo administration

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Editorial
Venue
The Journal of allergy and clinical immunology
Published
Subject terms
Humans; Adult; Middle Aged; Female; Male; Angioedemas, Hereditary; CRISPR-Cas Systems; Gene Editing; Gene knockout; Kallikrein; Hereditary Angioedema; Lipid Nanoparticle
PubMed ID
38925443
Added to directory
Source checked

Report a correction or request removal